{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:52:27Z","timestamp":1790272347881,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017585","name":"First Hospital of Jilin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017585","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014386","name":"Abbott Diagnostics","doi-asserted-by":"publisher","award":["ADD-China-2016"],"award-info":[{"award-number":["ADD-China-2016"]}],"id":[{"id":"10.13039\/100014386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972726"],"award-info":[{"award-number":["81972726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273074"],"award-info":[{"award-number":["82273074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018776","name":"Cancer Center, University of Florida Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008081","name":"Southeast University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.hbpd.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T11:27:32Z","timestamp":1703935652000},"page":"412-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score"],"prefix":"10.1016","volume":"24","author":[{"given":"Li-Yang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Kang","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-Ping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Da","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yee","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Yue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2023.12.004_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0003","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep.1840190111","article-title":"Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma","volume":"19","author":"Oka","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2009.10.031","article-title":"Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma","volume":"138","author":"Lok","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0006","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1158\/1055-9965.EPI-16-0747","article-title":"Improved performance of serum alpha-fetoprotein for hepatocellular carcinoma diagnosis in HCV cirrhosis with normal alanine transaminase","volume":"26","author":"Yang","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0007","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bpg.2014.07.018","article-title":"Hepatocellular carcinoma tumour markers: current role and expectations","volume":"28","author":"Rich","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0008","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.21873\/invivo.11413","article-title":"PIVKA-II as a potential new biomarker for hepatocellular carcinoma - a pilot study","volume":"32","author":"Svobodova","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0009","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cca.2013.08.005","article-title":"Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis","volume":"425","author":"Yi","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0010","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","article-title":"Biomarkers for the early diagnosis of hepatocellular carcinoma","volume":"21","author":"Tsuchiya","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0011","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/cells9061370","article-title":"Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment","volume":"9","author":"Pi\u00f1ero","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0012","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/j.seminoncol.2012.05.009","article-title":"New serum markers of hepatocellular carcinoma","volume":"39","author":"Masuzaki","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0013","doi-asserted-by":"crossref","first-page":"e5811","DOI":"10.1097\/MD.0000000000005811","article-title":"Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma","volume":"96","author":"Park","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0014","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cgh.2015.12.042","article-title":"Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients","volume":"14","author":"Berhane","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0016","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","article-title":"GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis","volume":"18","author":"Best","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0017","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0018","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1373\/clinchem.2019.308965","article-title":"A novel online calculator based on serum biomarkers to detect hepatocellular carcinoma among patients with hepatitis B","volume":"65","author":"Yang","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0019","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0020","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202009010","article-title":"Hepatitis C virus","volume":"173","author":"Kaplan","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0022","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0023","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Practice guidelines committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0024","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0026","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ajg.2015.100","article-title":"Alpha-fetoprotein measurement benefits hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"110","author":"Chang","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0027","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0028","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0029","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment","volume":"38","author":"Zhou","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","article-title":"Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA","volume":"18","author":"Ye","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0031","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","article-title":"Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma","volume":"68","author":"Ren","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103661","article-title":"The altered serum lipidome and its diagnostic potential for non-alcoholic fatty liver (NAFL)-associated hepatocellular carcinoma","volume":"73","author":"Lewinska","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0033","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000343847","article-title":"Alpha-fetoprotein-L3: Useful or useless for hepatocellular carcinoma?","volume":"2","author":"Kudo","year":"2013","journal-title":"Liver Cancer"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0034","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/j.1572-0241.2007.01405.x","article-title":"Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis","volume":"102","author":"Sterling","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cgh.2021.01.043","article-title":"DCP and AFP-L3 are complementary to AFP in predicting high-risk explant features: results of a prospective study","volume":"20","author":"Kotwani","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0036","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00535-010-0278-5","article-title":"AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC","volume":"45","author":"Yamamoto","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0037","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1349-7006.2011.01875.x","article-title":"Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng\/mL","volume":"102","author":"Toyoda","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hbpd.2023.12.004_bib0038","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1053\/j.gastro.2004.09.024","article-title":"Newer markers for hepatocellular carcinoma","volume":"127","author":"Marrero","year":"2004","journal-title":"Gastroenterology"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223002424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223002424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:36:24Z","timestamp":1762547784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387223002424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1499387223002424"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.12.004","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}